Mackenzie Maximum Divers All Wld Dev ETF (MWD.TO)
24.80
+0.42 (+1.72%)
CAD |
TSX |
Jul 06, 16:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.55% | -0.10% | 367.42M | 2055.10 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 1.32% | 37.04% | -21.52M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to replicate, to the extent reasonably possible and before fees and expenses, the performance of the TOBAM Maximum Diversification All World Developed Index, or any successor thereto. It invests primarily in equity securities of developed world markets. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Global Equity |
| Category Index | Morningstar Gbl Mkts GR CAD |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Mackenzie Financial Corporation |
| Prospectus Benchmark Index | |
| TOBAM Max Div AW Dvlp TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Doug Kean | 5.82 yrs |
| Matthew Cardillo | 5.82 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
85
-21.52M
-534.39M
Category Low
4.142B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of June 30, 2022
Performance Versus Category
As of July 06, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of July 06, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Apple Inc | 1.54% | 144.43 | 1.06% |
| Moderna Inc | 1.47% | 164.61 | 3.16% |
| Newmont Corp | 1.32% | 60.56 | 1.87% |
| The Kroger Co | 1.20% | 48.22 | 1.73% |
| Biogen Inc | 1.20% | 216.92 | 0.44% |
| Pfizer Inc | 1.11% | 53.39 | 1.21% |
| Eli Lilly and Co | 1.05% | 327.80 | -0.71% |
| Johnson & Johnson | 0.98% | 178.45 | 0.08% |
| Franco-Nevada Corp | 0.97% | 171.35 | 0.08% |
| Zoom Video Communications Inc | 0.95% | 119.00 | 1.66% |
News
Headline
Wire
Time (ET)
PR Newswire
06/14 16:27
PR Newswire
12/10 14:26
Mackenzie Investments Announces September 2021 Quarterly Distributions for its Exchange Traded Funds
PR Newswire
09/14 11:29
PR Newswire
06/15 09:14
PR Newswire
03/16 10:43
PR Newswire
12/15 14:02
PR Newswire
12/11 15:36
PR Newswire
11/16 11:21
Basic Info
| Investment Strategy | |
| The investment seeks to replicate, to the extent reasonably possible and before fees and expenses, the performance of the TOBAM Maximum Diversification All World Developed Index, or any successor thereto. It invests primarily in equity securities of developed world markets. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Global Equity |
| Category Index | Morningstar Gbl Mkts GR CAD |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Mackenzie Financial Corporation |
| Prospectus Benchmark Index | |
| TOBAM Max Div AW Dvlp TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Doug Kean | 5.82 yrs |
| Matthew Cardillo | 5.82 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (7-6-22) | 1.32% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 15.91 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of July 05, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 9/7/2016 |
| Last Annual Report Date | 3/31/2022 |
| Last Prospectus Date | 7/21/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
PR Newswire
06/14 16:27
PR Newswire
12/10 14:26
Mackenzie Investments Announces September 2021 Quarterly Distributions for its Exchange Traded Funds
PR Newswire
09/14 11:29
PR Newswire
06/15 09:14
PR Newswire
03/16 10:43
PR Newswire
12/15 14:02
PR Newswire
12/11 15:36
PR Newswire
11/16 11:21